Vext Science management commentary cites inventory costs, lower output as drivers of Q3 2026 margin decline

Bitget2026/11/03 11:52

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vext Science management commentary linked revenue growth for the quarter ended September 30, 2026 to Ohio expansion and wholesale flower sales.
Revenue rose 17.6% year over year to USD 14.9 million, led by Fairfield's first full quarter and higher Ohio wholesale sales.
Net loss widened to USD 4.88 million from USD 2.63 million a year earlier, reflecting margin pressure and higher operating expenses.
Gross margin before fair-value adjustments fell sequentially to 21.7% from 44%, reflecting inventory sell-through costs and overhead unabsorbed at lower output.
Adjusted EBITDA dropped sequentially to USD 195,000 from USD 3.44 million; the Jackson closure and Vapen product hold also hurt performance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vext Science Inc. published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vext Science management commentary cites inventory costs, lower output as drivers of Q3 2026 margin decline

You may also like

Crypto prices